Multiple myeloma is on the list of neoplasia that may be associated with human immunodeficiency virus infection. It is an affection that aggravates the prognosis in these particular patients. We present the case of a patient with multiple myeloma and HIV infection, revealed by renal failure. This was a 59-year-old patient who was received to the Department of nephrology for renal failure associated with severe aregenerative pancytopenia. In etiological investigations, multiple myeloma associated with HIV1 infection was found. The evolution was unfavorable, marked by the death of the patient caused by digestive haemorrhage before the start of antiretroviral treatment and chemotherapy.
Delèvaux, I., Bernard, N., Ramanampamonjy, R., Morlat, P., Lacoste, D., Bonnet, F., et al. (2000) Plasmocytomes multiples médullaires et extramédullaires chez une patiente infectée par le VIH [Multiple Medullary and Extramedullary Plasmocytoma in an HIV-Infected Female Patient]. La Revue de Médecine Interne, 21, 623-627. https://doi.org/10.1016/S0248-8663(00)80008-9
Shirai, A., Cosentino, M., Leitman-Klinman, S.F. and Klinman, D.M. (1992) Human Immunodeficiency Virus Infection Induces Both Polyclonal and Virusspecific B Cell Activation. Journal of Clinical Investigation, 89, 561-566. https://doi.org/10.1172/JCI115621
De Milito, A., Nilsson, A., Titanji, K., Thorstensson, R., Reizenstein, E., Narita, M., Grutzmeier, S., Sonnerborg, A. and Chiodi, F. (2004) Mechanisms of Hypergammaglobulinemia and Impaired Antigen-Specific Humoral Immunity in HIV-1 Infection. Blood, 103, 2180-2186. https://doi.org/10.1182/blood-2003-07-2375
Grulich, A.E., van Leeuwen, M.T., Falster, M.O. and Vajdic, C.M. (2007) Incidence of Cancers in People with HIV/AIDS Compared with Immunosuppressed Transplant Recipients: A Meta-Analysis. The Lancet, 370, 59-67. https://doi.org/10.1016/S0140-6736(07)61050-2
Dal Maso, L. and Franceschi, S. (2003) Epidemiology of non-Hodgkin Lymphomas and Other Haemolymphopoietic Neoplasms in People with AIDS. The Lancet Oncology, 4, 110-119. https://doi.org/10.1016/S1470-2045(03)00983-5
Feller, L., White, J., Wood, N.H., Bouckaert, M., Lemmer, J. and Raubenheimer, E.J. (2009) Extramedullary Myeloma in an HIV-Seropositive Subject. Literature Review and Report of an Unusual Case. Head & Face Medicine, 5, 4. https://doi.org/10.1186/1746-160X-5-4
Pouli, A., Lemessiou, H., Rontogianni, D., Papanastassiou, C., Tsakanikas, S., Gerassimou, A. and Stamatelou, M. (2001) Multiple Myeloma as the First Manifestation of Acquired Immunodeficiency Syndrome: A Case Report and Review of the Literature. Annals of Hematology, 80, 557-560. https://doi.org/10.1007/s002770100339
Cauda, R., Lucia, M.B., Marasca, G., Rutella, S., Petrucci, M.T., La Verde, G. and Gastaldi, R. (1999) Beneficial Effect of Highly Active Antiretroviral Therapy (HAART) in Reducing Both HIV Viral Load and Monoclonal Gammopathy. European Journal of Haematology, 63, 134-135. https://doi.org/10.1111/j.1600-0609.1999.tb01127.x
Gimeno, L.S.E., Abella, E., Perez-Vila, E., Cervera, M., Montero, M., Gimenez, M.T., Knobel, H. and Besses, C. (2007) Complete Remission of Smoldering Myeloma in an HIV Patient after Highly Antiretroviral Therapy. Haematologica, 92, 485.
Ikezoe, T., Saito, T., Bandobashi, K., Yang, Y., Koeffler, H.P. and Taguchi, H. (2004) HIV-1 Protease Inhibitor Induces Growth Arrest and Apoptosis of Human Multiple Myeloma Cells via Inactivation of Signal Transducer and Activator of Transcription 3 and Extracellular Signal-Regulated Kinase 1/2. Molecular Cancer Therapeutics, 3, 473-479.
Kawabata, S., Gills, J.J., Mercado-Matos, J.R., Lopiccolo, J., Wilson, W., Hollander 3rd, M.C. and Dennis, P.A. (2012) Synergistic Effects of Nelfinavir and Bortezomib on Proteotoxic Death of NSCLC and Multiple Myeloma Cells. Cell Death & Disease, 3, e353. https://doi.org/10.1038/cddis.2012.87